Literature DB >> 14988454

Dietary L-arginine supplementation enhances endothelial nitric oxide synthesis in streptozotocin-induced diabetic rats.

Ripla Kohli1, Cynthia J Meininger, Tony E Haynes, Wene Yan, Jon T Self, Guoyao Wu.   

Abstract

This study tested the hypothesis that dietary arginine supplementation increases endothelial tetrahydrobiopterin (BH(4)) availability for nitric oxide (NO) synthesis in diabetic rats. Streptozotocin-induced diabetic rats either were given unrestricted access to a casein-based diet (Expt. 1) or were pair-fed the diet on the basis of the food intake per kg of body weight of nondiabetic rats (Expt. 2). Beginning 1 d after vehicle or streptozotocin injection, arginine-HCl (1.51%) or alanine (isonitrogenous control, 2.55%) was added daily to the drinking water for nondiabetic rats, whereas concentrations were adjusted (0.43% arginine-HCl and 0.73% alanine) in the drinking water for diabetic rats (which consumed more water) to ensure isonitrogenous provision. At 2 wk after the initiation of arginine supplementation, coronary endothelial cells and plasma were obtained for the measurement of NO synthesis and metabolites. In both experiments, plasma and endothelial concentrations of N(G)-monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine increased, but those of arginine as well as endothelial BH(4) availability and NO synthesis decreased in diabetic rats, compared with nondiabetic rats. In both diabetic and nondiabetic rats, arginine supplementation increased plasma concentrations of arginine and insulin, endothelial concentrations of arginine and BH(4), and endothelial NO synthesis, but did not affect plasma and endothelial concentrations of methylarginines or plasma concentrations of homocysteine. Dietary arginine supplementation or provision of a BH(4) precursor normalized endothelial NO synthesis in diabetic rats. Arginine supplementation did not affect plasma glucose levels in nondiabetic rats, but reduced body weight loss and plasma glucose levels in diabetic rats. Thus, dietary L-arginine supplementation stimulates endothelial NO synthesis by increasing BH(4) provision, which is beneficial for vascular function and glucose homeostasis in diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988454     DOI: 10.1093/jn/134.3.600

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  34 in total

1.  Oral administration of α-ketoglutarate enhances nitric oxide synthesis by endothelial cells and whole-body insulin sensitivity in diet-induced obese rats.

Authors:  Carmen D Tekwe; Kang Yao; Jian Lei; Xilong Li; Anand Gupta; Yuanyuan Luan; Cynthia J Meininger; Fuller W Bazer; Guoyao Wu
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-29

2.  Tetrahydrobiopterin, L-arginine and vitamin C actsynergistically to decrease oxidative stress, increase nitricoxide and improve blood flow after induction of hindlimbischemia in the rat.

Authors:  Jinglian Yan; Guodong Tie; Louis M Messina
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

3.  Tetrahydrobiopterin: important endothelial mediator independent of endothelial nitric oxide synthase.

Authors:  Cynthia J Meininger; Guoyao Wu
Journal:  Hypertension       Date:  2011-06-27       Impact factor: 10.190

4.  The Citrulline Recycling Pathway Sustains Cardiovascular Function in Arginine-Depleted Healthy Mice, but Cannot Sustain Nitric Oxide Production during Endotoxin Challenge.

Authors:  Yang Yuan; Mahmoud A Mohammad; Ancizar Betancourt; Inka C Didelija; Chandrasekar Yallampalli; Juan C Marini
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

5.  L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration.

Authors:  Lusliany J Rondón; M C Farges; N Davin; B Sion; A M Privat; M P Vasson; A Eschalier; C Courteix
Journal:  Eur J Nutr       Date:  2017-07-19       Impact factor: 5.614

6.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

7.  L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Authors:  P Pennisi; G Clementi; A Prato; T Luca; G Martinez; R A Mangiafico; I Pulvirenti; F Muratore; C E Fiore
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

8.  Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis.

Authors:  Tung-Ming Leung; George L Tipoe; Emily C Liong; Thomas Y H Lau; Man-Lung Fung; Amin A Nanji
Journal:  Int J Exp Pathol       Date:  2008-04-21       Impact factor: 1.925

9.  Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats.

Authors:  Wenjuan Jobgen; Cynthia J Meininger; Scott C Jobgen; Peng Li; Mi-Jeong Lee; Stephen B Smith; Thomas E Spencer; Susan K Fried; Guoyao Wu
Journal:  J Nutr       Date:  2008-12-23       Impact factor: 4.798

Review 10.  Renal endothelial dysfunction in diabetic nephropathy.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.